?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
April 16, 2025
signalgroup
Biosimilars Forum Applauds the Trump Administration for Drug Pricing Executive Order
News
April 15, 2025
signalgroup
Biosimilars Forum Statement on Tariffs Impacting Low Cost Medicines
News
April 8, 2025
signalgroup
Biosimilars Forum Urges Congressional Action on Biosimilars
News
April 2, 2025
signalgroup
Biosimilars Forum Supports the FDA, Its Employees, and Its Mission
News
March 26, 2025
signalgroup
Biosimilars Forum Executive Director Juliana Reed to Speak at Evolution of Biosimilars Development Workshop
News
March 24, 2025
signalgroup
Biosimilars Forum Chair of Scientific Affairs Committee to Speak at the Festival of Biologics USA
News
December 12, 2024
Katie Quinn
Biosimilars Forum Welcomes Henlius as Newest Member
News
August 15, 2024
Katie Quinn
Biosimilars Forum Calls on CMS to Support Lower-Cost Biosimilars and Increase Access for Patients
News
July 24, 2024
signalgroup
The Biosimilars Forum Supports House Committee on Oversight and Accountability Probe Into the PBM Monopoly
News
July 9, 2024
signalgroup
Biosimilars Forum Calls for Reform of the PBM Monopoly
01
02
03
Next page